Cancer Letters
Volume 234, Issue 2 , Pages 193-198 , 28 March 2006

Increased thromboxane B2 levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma

  • George G. Chen

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • Corresponding Author InformationCorresponding author. Address: Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong. Tel.: +852 2632 3934; fax: +852 2645 0605.
    • ,
  • Tak W. Lee

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • ,
  • Johnson H.Y. Yip

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • ,
  • Hu Xu

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • ,
  • Isa K.Y. Lee

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • ,
  • Tony S.K. Mok

      Affiliations

    • Department of Clinical Oncology, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong
    • ,
  • Timothy D. Warner

      Affiliations

    • The William Harvey Research Institute, Barts and the London, Queen Mary University of London, London, UK
    • ,
  • Anthony P.C. Yim

      Affiliations

    • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong

Received 25 October 2004 ,Revised 18 March 2005 ,Accepted 23 March 2005.

References 

  1. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic. Biol. Med. 1994;16:99–109
  2. Wardlaw SA, March TH, Belinsky SA. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis. 2000;21:1371–1377
  3. Hida T, Kozaki K, Ito H, Miyaishi O, Tatematsu Y, Suzuki T, et al. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Clin. Cancer Res. 2002;8:2443–2447
  4. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262:1274–1277
  5. van Ginkel G, Sevanian A. Lipid peroxidation induced membrane structural alterations. Methods Enzymol. 1994;233:273–288
  6. Petruzzelli S, Hietanen E, Bartsch H, Camus AM, Mussi A, Angeletti CA, et al. Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients. Chest. 1990;98:930–935
  7. Zieba M, Nowak D, Suwalski M, Piasecka G, Grzelewska-Rzymowska I, Tyminska K, et al. Enhanced lipid peroxidation in cancer tissue homogenates in non-small cell lung cancer. Monaldi Arch. Chest Dis. 2001;56:110–114
  8. Zieba M, Suwalski M, Kwiatkowska S, Piasecka G, Grzelewska-Rzymowska I, Stolarek R, et al. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir. Med. 2000;94:800–805
  9. Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J. Clin. Pharm. Ther. 2001;26:141–144
  10. Fahn HJ, Wang LS, Kao SH, Chang SC, Huang MH, Wei YH. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am. J. Respir. Cell Mol. Biol. 1998;19:901–909
  11. Hanaoka T, Nakayama J, Mukai J, Irie S, Yamanda T, Sato TA. Association of smoking with apoptosis-regulated proteins (Bcl-2, bax and p53) in resected non-small-cell lung cancers. Int. J. Cancer. 2001;91:267–269
  12. Britigan BE, Rasmussen GT, Cox CD. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect. Immun. 1997;65:1071–1076
  13. Pinto S, Gori L, Gallo O, Boccuzzi S, Paniccia R, Abbate R. Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx. Prostaglandins Leukot. Essent. Fatty Acids. 1993;49:527–530
  14. Nigam S, Zakrzewicz A, Eskafi S, Roscher A. Clinical significance of prostacyclin and thromboxane in cancer of the female breast and genital tract. Cancer Metastasis Rev. 1992;11:411–420
  15. Fujimura M, Kasahara K, Shirasaki H, Heki U, Iwasa K, Ueda A, et al. Up-regulation of ICH-1L protein by thromboxane A2 antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines. J. Cancer Res. Clin. Oncol. 1999;125:389–394
  16. Kalomenidis I, Orphanidou D, Papamichalis G, Vassilakopoulos T, Scorilas A, Rasidakis A, et al. Combined expression of p53 Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics. Lung. 2001;179:265–278
  17. Ohmura Y, Aoe M, Andou A, Shimizu N. Telomerase activity and Bcl-2 expression in non-small cell lung cancer. Clin. Cancer Res. 2000;6:2980–2987
  18. Tanizawa H, Iwanaga T, Tai HH. Increase in thromboxane B2 and decrease in prostaglandin E2 and 6-keto-prostaglandin F1 alpha release into rat bronchoalveolar fluid as a consequence of cigarette smoking. Prostaglandins Leukot. Med. 1987;28:195–201
  19. Morin CL, Allen KG, Mathias MM. Thromboxane production in copper-deficient and marginal platelets: influence of superoxide dismutase and lipid hydroperoxides. Proc. Soc. Exp. Biol. Med. 1993;202:167–173
  20. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am. J. Obstet. Gynecol. 1992;167:946–949
  21. Dosaka-Akita H, Katabami M, Hommura H, Fujioka Y, Katoh H, Kawakami Y. Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status. Oncology. 1999;56:259–264
  22. Fleming MV, Guinee DG, Chu WS, Freedman AN, Caporaso NE, Bennett WP, et al. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. Hum. Pathol. 1998;29:60–64
  23. Wang HY, Shin VY, Leung SY, Yuen ST, Cho CH. Involvement of bcl-2 and caspase-3 in apoptosis induced by cigarette smoke extract in the gastric epithelial cell. Toxicol. Pathol. 2003;31:220–226

PII: S0304-3835(05)00285-5

doi: 10.1016/j.canlet.2005.03.032

Cancer Letters
Volume 234, Issue 2 , Pages 193-198 , 28 March 2006

Article Tools

* Image Usage & Resolution